openPR Logo
Press release

World conference on STDs, STIs & HIV/AIDS

12-30-2016 09:31 AM CET | Science & Education

Press release from: Allied academies

"World Conference on STDs, STIs & HIV/AIDS is a leading Conference in Canada, the program will explore new scientific knowledge and provides a platform for professionals and community members to participate in a structured dialogue on the major issues. The main objective will be to share scientific discoveries and clinical care on HIV and STDs, HIV diagnosis and therapy that would comprise various methods to diagnose HIV, HIV drug discovery, viral and bacterial STDs, STIs, like Herpes, HPV etc., strategies for HIV and STDs prevention, bioethics etc. As HIV/AIDS is an alarming concern throughout the world, STDs & HIV/AIDS-2017 will mainly focus on issues like Primary HIV Infection, Transmission and Eradication Issues apart from this,The genetic approaches towards prevention of HIV & STDs, HIV Co-infection, HIV ongoing pharmaceutical design would cover the experimental drugs developed. STDs & HIV/AIDS-2017, lays perfect platform for Medical professionals, physicians, nurse-practitioners, pharmacists, psychologists, behavioral researchers, Health care professionals, social scientists, epidemiologists, social workers, AIDS service organization (ASO) staff, students, Academicians who are working in the field of HIV & STDs medicine.

Join us in Vancouver,Canada for the Worlds leading conference event."

Allied academies conferences

154 Chestnut Creek Road
Candler, NC 28715, USA

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release World conference on STDs, STIs & HIV/AIDS here

News-ID: 403062 • Views:

More Releases from Allied academies

Are you passionate about nanoscience and its impact on healthcare? Then mark your calendars for the Nanoscience Conference 2023
Are you passionate about nanoscience and its impact on healthcare? Then mark you …
Nanoscience 2023 UPDATE!! Meet you all in Madrid, Spain on December 07-09, 2023. We ecstatically welcome you all to the "27th International Conference on Advanced Nanoscience and Nanotechnology". This conference is meticulously scheduled during December 07-09, 2023 in Madrid, Spain. For more details, please visit: https://nanoscience.alliedacademies.com With an exciting theme, "Investigate the future prospects in Nanoscience and Nanotechnology", this year we can provide you with a world-class scientific program spanning all areas of
Stress Management 2023
Globally, the COVID-19 pandemic affected not only the financial status but also the mental health of the individuals drastically which increased the stress management market to USD 18,700.9 million and expected to increase at a CAGR of 3.8% during the forecast period. Globally, 10% of the children encounter any least one of the mental disorders. The preliminary treatment could be discussing the issue with the cherished circle, whereas professional
Current trends in Rheumatology, Orthopedics, and Arthroplasty
Current trends in Rheumatology, Orthopedics, and Arthroplasty
2nd International Conference on Rheumatology, Orthopedics and Arthroplasty December 05-06, 2022 | Dubai, UAE Theme: Current Trends in Rheumatology, Orthopedics and Arthroplasty Rheumatology 2022 will provide an international platform for all Speakers, Delegates, Surgeons, Research Scholars, Orthopedic Physicians, Orthopedic Surgeons, Rheumatologists, Orthopedic and Rheumatology Research Fellows, Orthopedic and Rheumatology Faculty, Directors and Chair Persons, Health Care Professionals, Orthopedic and Rheumatology Medical Students, Orthopedics Medical Colleges, Universities, Orthopedics Devices Designers etc. Audience Profile: ·
4th International Conference on Materials Science and Materials Chemistry
The 4th International conference on Materials Science and Materials Chemistry is an international Scientific gathering which provides a common place for all the stakeholders of materials research and industry as like scientists, researchers, industrialists, entrepreneurs, start-ups, young research fellows, academic institutions, laboratories and many others to share and discuss the current trends in Materials Research. Come and explore the trends in materials research! To register: https://materialschemistry.alliedacademies.com/registration For brochure: https://materialschemistry.alliedacademies.com/brochure-download To submit your abstract:

All 4 Releases


More Releases for HIV

HIV-Associated Lipodystrophy Treatment Market - Increasing prevalence of HIV is …
HIV-associated lipodystrophy also known as lipodystrophy is a syndrome that occurs in HIV-infected patients. It is characterized by loss of subcutaneous fat from face, buttocks, arms and legs. Although the exact cause of HIV-associated lipodystrophy is not fully elucidated, some research evidence reported that it occurs in HIV-infected patients who are under antiretroviral medications. According to an article published in National Center for Biotechnology Information (NCBI) in 2014, prevalence of
Global HIV Drugs Market | Global HIV Drugs Industry | Global HIV Drugs Market Re …
Human immunodeficiency Virus (HIV) could be a chronic and severe sickness which might be transferred from one person to a different through blood-to-blood and sexual contact. it's a deadly disease that attacks immune cells called CD-4 cells, creating body vulnerable to infections and alternative diseases. Over the years, the rising prevalence of HIV sickness worldwide has completely influenced the demand for HIV medicine. HIV medicine facilitate in preventing the multiplication
HIV Therapeutics Market– South Africa's Aspen launches three-in-one HIV drug
Recent Developments Aspen Pharma care, a South Africa’s drug maker has launched a triple combination of tablet for the treatment of HIV in the country where the HIV virus is the most prevalent. The company's new Emdolten drug is a once a day tablet which is in the form of dolutegravir, an antiretroviral medication that balances the drug’s resistance. The company has launched Aspen Stavudine which was its first generic ARV
HIV Vaccine Market HIV Vaccine Clinical Pipeline Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents Introduction to Human Immunodeficiency Virus (HIV) Vaccines 1.1 Overview 1.2 Antiquity of HIV Vaccine Need for the Development of HIV Vaccine Primer of HIV inside the Body 3.1 Inclusion of HIV Virus into the System 3.2 Interaction of HIV with Host 3.3 Eradication of HIV Virus HIV Vaccine Development Process 4.1 Introduction
Global HIV Vaccine Market & HIV Vaccine Clinical Trial Outlook 2022
Worldwide, around the 35 Million of the people are currently infected with the HIV and about 30 Million of the people died because of the AIDS infection. There is no human example of clearing an HIV infection naturally. HIV virus makes copies of it very quickly, many types of HIV exist and new types of virus are continue to rise. Many scientists are still trying to understand the specific ways
Hidden HIV Revealed: New Insights Into Latent HIV Infections
In spite of ever more effective therapies, HIV keeps managing to survive in the body. A comprehensive project conducted by the Austrian Science Fund FWF has clarified the molecular processes which contribute to this effect. In the process, approaches were discovered for possible therapies to combat the hidden reservoir formed by the virus. Thanks to modern therapies, HIV infections have become controllable – but these treatments cannot provide a cure. Antiretroviral